T. Rowe Price Investment Management, Inc. Elanco Animal Health Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 15,983,391 shares of ELAN stock, worth $224 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
15,983,391
Previous 15,690,736
1.87%
Holding current value
$224 Million
Previous $190 Million
11.68%
% of portfolio
0.11%
Previous 0.12%
Shares
7 transactions
Others Institutions Holding ELAN
# of Institutions
408Shares Held
452MCall Options Held
718KPut Options Held
671K-
Dodge & Cox San Francisco, CA82.9MShares$1.16 Billion0.53% of portfolio
-
Primecap Management CO Pasadena, CA50.2MShares$703 Million0.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.3MShares$676 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$326 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A622MShares$308 Million11.21% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.63B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...